Allelotype of 28 human breast cancer cell lines and xenografts

I C Harkes1, F Elstrodt, W N M Dinjens

  • 1Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands.

British Journal of Cancer
|December 17, 2003
PubMed

Insights

This study identified frequently deleted chromosomal regions in breast cancer cell lines using microsatellite analysis. These findings aid in discovering new tumor suppressor genes and provide a baseline for future breast cancer research.

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Tumor suppressor genes are often inactivated by heterozygous loss of large chromosomal regions.
  • Identifying these deletions in cancer genomes is a key strategy for discovering novel tumor suppressor genes.

Purpose of the Study:

  • To conduct a genome-wide survey for allelic losses in breast cancer cell lines and xenografts.
  • To identify frequently deleted chromosomal regions that may harbor tumor suppressor genes.
  • To establish a comprehensive allelotype for breast cancer research.

Main Methods:

  • Genome-wide survey using microsatellite analysis.
  • Analysis of 24 breast cancer cell lines and 4 breast cancer xenografts.
  • Determination of allelic loss frequencies across chromosomal arms.

Main Results:

  • An average fractional allelic loss of 0.34 was observed.
  • Five chromosomal arms (8p, 10q, 13q, 17p, and 17q) were deleted in over 50% of samples.
  • Microsatellite analysis demonstrated higher sensitivity in detecting allelic losses compared to comparative genome hybridization for certain regions.

Conclusions:

  • The generated allelotype provides valuable data for identifying new breast cancer genes.
  • The study highlights the utility of microsatellite analysis for detecting allelic losses.
  • This allelotype serves as a foundational resource for future breast cancer studies.

Related Concept Videos